Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Thirty-Day Mortality Following Systemic Anticancer Therapy: Evaluating Risk Factors Without Selection Bias in a Real-World, Population-Based Cohort From 2009 to 2019.
Clin Oncol (R Coll Radiol). 2022 Aug;34(8):487-496. doi: 10.1016/j.clon.2022.03.015. Epub 2022 Apr 7.
Clin Oncol (R Coll Radiol). 2022.
PMID: 35400599
Free article.
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study.
Mouritzen MT, Junker KF, Carus A, Ladekarl M, Meldgaard P, Nielsen AWM, Livbjerg A, Larsen JW, Skuladottir H, Kristiansen C, Wedervang K, Schytte T, Hansen KH, Østby AC, Frank MS, Lauritsen J, Sørensen JB, Langer SW, Persson GF, Andersen JL, Homann PH, Kristensen EB, Drivsholm LB, Bøgsted M, Christensen HS, Pøhl M, Bjørnhart B.
Mouritzen MT, et al.
Acta Oncol. 2022 Apr;61(4):409-416. doi: 10.1080/0284186X.2021.2023213. Epub 2022 Jan 11.
Acta Oncol. 2022.
PMID: 35012430
Item in Clipboard
Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy.
Mouritzen MT, Carus A, Ladekarl M, Meldgaard P, Nielsen AWM, Livbjerg A, Larsen JW, Skuladottir H, Kristiansen C, Wedervang K, Schytte T, Hansen KH, Østby AC, Frank MS, Lauritsen J, Sørensen JB, Langer SW, Persson GF, Andersen JL, Frary JMC, Drivsholm LB, Vesteghem C, Christensen HS, Bjørnhart B, Pøhl M.
Mouritzen MT, et al.
Cancers (Basel). 2021 Sep 28;13(19):4846. doi: 10.3390/cancers13194846.
Cancers (Basel). 2021.
PMID: 34638329
Free PMC article.
Item in Clipboard
Gene Expressions and High Lymphocyte Count May Predict Durable Clinical Benefits in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
Mouritzen MT, Ladekarl M, Hager H, Mattesen TB, Lippert JB, Frank MS, Nøhr AK, Egendal IB, Carus A.
Mouritzen MT, et al.
Cancers (Basel). 2023 Sep 8;15(18):4480. doi: 10.3390/cancers15184480.
Cancers (Basel). 2023.
PMID: 37760450
Free PMC article.
Item in Clipboard
5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy.
Bjørnhart B, Mouritzen MT, Kristiansen C, Schytte T, Wedervang K, Pøhl M, Holmskov Hansen K.
Bjørnhart B, et al. Among authors: mouritzen mt.
Acta Oncol. 2023 Aug;62(8):861-870. doi: 10.1080/0284186X.2023.2238544. Epub 2023 Aug 3.
Acta Oncol. 2023.
PMID: 37534770
Item in Clipboard
Treatment of induced oligometastatic disease after partial response to immunochemotherapy in patient with stage IV non-small cell lung cancer and severe toxicity.
Mughal HA, Mouritzen MT, Takacs-Szabó Z, Szejniuk WM.
Mughal HA, et al. Among authors: mouritzen mt.
BMJ Case Rep. 2022 Dec 14;15(12):e252590. doi: 10.1136/bcr-2022-252590.
BMJ Case Rep. 2022.
PMID: 36517080
Item in Clipboard
Cite
Cite